What if we could detect a lung cancer patient’s relapse months before it’s visible on scans? A recent study in Nature Magazine sheds light on the powerful potential of molecular residual disease (MRD) analysis. #lungcancer

Comments

Posting Rules

  • Be respectful to others
  • No spam or self-promotion
  • Stay on topic
  • Follow Bluesky's terms of service